Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat-angiogenesis and angioma formation

Journal of the American College of Cardiology

Volumn 35, Issue 5, 2000, Pages 1323-1330

  Schwarz, Ernst R ^a,b   Speakman, Mark T ^a,b   Patterson, Mike ^a   Hale, Sharon S ^a   Isner, Jeffrey M ^c   Kedes, Laurence H ^b   Kloner, Robert A ^a,b  

^a GOOD SAMARITAN HOSPITAL   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMID DNA; RADIOACTIVE MICROSPHERE; SODIUM CHLORIDE; VASCULOTROPIN;

ANGIOGENESIS; ANGIOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY LIGATION; DISEASE MODEL; GENE EXPRESSION; GENE THERAPY; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE BLOOD FLOW; HISTOLOGY; INJECTION SITE; MORPHOMETRICS; NONHUMAN; PLASMID; PRIORITY JOURNAL; RAT;

ANIMALS; CORONARY CIRCULATION; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; ENDOTHELIAL GROWTH FACTORS; GENE THERAPY; HEART NEOPLASMS; HEMANGIOMA; INJECTIONS; LYMPHOKINES; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; PLASMIDS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034116631     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)00522-2     Document Type: Article

References (50)

1. Namiki A., Brogi E., Kearney M., et al. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J Biol Chem. 270:1995;31189-31195.
2. Schaper W., Ito W.D. Molecular mechanisms of coronary collateral vessel growth. Circ Res. 79:1996;911-919.
3. Schaper W., Schaper J. Collateral Circulation Heart, Brain, Kidney, Limbs . 1993;Kluwer Academic Publishers, Dordrecht.
4. Mellilo G., Scoccianti M., Kovesdi I., Safi J.J., Riccioni T., Capogrossi M.C. Gene therapy for collateral vessel development. Cardiovasc Res. 35:1997;480-489.
5. Lewis B.S., Flugelman M.Y., Weisz A., Keren-Tal I., Schaper W. Angiogenesis by gene therapy a new horizon for myocardial revascularization . Cardiovasc Res. 35:1997;490-497.
6. Safi J.J., Gloe T.R., Riccioni T., Kovesdi I., Capogrossi M.C. Gene therapy with angiogenic factors a new potential approach to the treatment of ischemic diseases . J Mol Cell Cardiol. 29:1997;2311-2325.
7. Ferrara N., Houck K.A., Jakeman L.B., Winer J., Leung D.W. The vascular endothelial growth factor family of polypeptides. J Cell Biochem. 47:1991;211-218.
8. Ferrara N., Houck K., Jakeman L., Leung D.W. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev. 13:1992;18-42.
9. Leung D.W., Cachianes G., Kuang W.J., Goeddel D.V., Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 246:1989;1306-1309.
10. Takeshita S., Zheng L.P., Brogi E., et al. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest. 93:1994;662-670.
11. Takeshita S., Pu L.Q., Stein L.A., et al. Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. Circulation. 90:1994;II228-II234.
12. Bauters C., Asahara T., Zheng L.P., et al. Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb after administration of vascular endothelial growth factor. Circulation. 91:1995;2802-2809.
13. Isner J.M., Pieczek A., Schainfeld R., et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischemic limb. Lancet. 348:1996;370-374.
14. Banai S., Jaklitsch M.T., Shou M., et al. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation. 89:1994;2183-2189.
15. Lazarous D.F., Shou M., Scheinowitz M., et al. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation. 94:1996;1074-1082.
16. Wolff J.A., Malone R.W., Williams P., et al. Direct gene transfer into mouse in vivo. Science. 247:1990;1465-1468.
17. Wolff J.A., Williams P., Ascadi G., Jiao S., Jani A., Chong W. Conditions affecting direct gene transfer into rodent muscle in vivo. Biotechniques. 11:1991;474-485.
18. Wolff J.A., Dowty M.E., Jiao S., et al. Expression of naked plasmids by cultured myotubes and entry of plasmids into T tubles and caveolae of mammalian skeletal muscle. J Cell Sci. 103:1992;1249-1259.
19. Jiao S., Williams P., Berg R.K., et al. Direct gene transfer into nonhuman primate myofibers in vivo. Hum Gene Ther. 3:1992;21-33.
20. Lin H., Parmacek M.S., Morle G., Bolling S., Leiden J. Expression of recombinant genes in myocardium in vivo after direct injection of DNA. Circulation. 82:1990;2217-2221.
21. Ascadi G., Jiao S., Jani A., et al. Direct gene transfer and expression into rat heart in vivo. New Biol. 3:1991;71-81.
22. Buttrick P.M., Kass M., Kitsis R.N., Kaplan M.L., Leinwand L.A. Behavior of genes directly injected into the rat heart in vivo. Circ Res. 70:1992;193-198.
23. Kitsis R.N., Buttrick P.M., McNally E.M., Kaplan M.L., Leinwand L.A. Hormonal modulation of a gene injected into rat heart in vivo. Proc Nat Acad Sci. 88:1991;4138-4142.
24. Prentice H, Sartorelli V, Kedes LH. Tissue specific gene regulation: emphasis on heart and skeletal muscle. In: Methods in Molecular Genetics. 1993;303-32.
25. Prentice H., Kloner R.A., Li Y., Newman L., Kedes L. Ischemic/reperfused myocardium can express recombinant protein following direct DNA or retroviral injection. J Mol Cell Cardiol. 28:1996;133-140.
26. Leor J., Quinones M.J., Patterson M., Kedes L., Kloner R.A. Adenovirus-mediated gene transfer into infarcted myocardium feasibility, timing and location of expression . J Mol Cell Cardiol. 28:1996;2057-2067.
27. Quinones M.J., Leor J., Kloner R.A., et al. Avoidance of immune response prolongs expression of genes delivered to the adult rat myocardium by replication-defective adenovirus. Circulation. 94:1996;1394-1401.
28. Leor J., Patterson M., Quinones M.J., Kedes L.H., Kloner R.A. Transplantation of fetal myocardial tissue into the infarcted myocardium of rat. A potential repair of infarcted myocardium. Circulation. 94:(Suppl II):1996;II332-II336.
29. Marme D. Tumor angiogenesis the pivotal role of vascular endothelial growth factor . World J Urology. 14:1996;166-174.
30. Plate K.H., Breier G., Weich H.A., Risau W. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature. 359:1992;845-848.
31. Banai S., Jaklitsch M.T., Casscells W., et al. Effects of acidic fibroblast growth factor in normal and ischemic myocardium. Circ Res. 69:1991;76-85.
32. 165 as sole therapy for myocardial ischemia. Circulation. 98:1998;2800-2804.
33. Asahara T., Bauters C., Pastore C., et al. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation. 91:1995;2793-2801.
34. Bauters C., Asahara T., Zheng L.P., et al. Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. J Vasc Surg. 21:1995;314-325.
35. Baumgartner I, Pieczek AM, Blair R, Manor O, Walsh K, Isner JM. Evidence of therapeutic angiogenesis in patients with critical limb ischemia after intramuscular phVEGF165 gene transfer (abstr). Circulation 1997;96 Suppl I:I-H.
36. Isner J.M., Walsh K., Symes J.F., et al. Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease. Hum Gene Ther. 7:1996;959-988.
37. Isner J.M., Walsh K., Symes J., et al. Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease. Circulation. 91:1995;2687-2692.
38. Henry T.D., Rocha-Singh K., Isner J.M., et al. Results of intracoronary recombinant human vascular endothelial growth factor (rhVEGF) administration trial. (abstr) J Am Coll Cardiol. 31:(Suppl A):1998;65A.
39. Majesky W.A. A little VEGF goes a long way. Therapeutic angiogenesis by direct injection of vascular endothelial growth factor-encoding plasmid DNA. Circulation. 94:1996;3062-3064.
40. Sabia P.J., Powers E.R., Ragosta M., Sarembock I.J., Burwell L.R., Kaul S. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N Engl J Med. 327:1992;1825-1831.
41. Katoh O., Tauchi H., Kawaishi K., Kimura A., Satow Y. Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation. Cancer Res. 55:1995;5687-5692.
42. Tolentino M.J., Miller J.W., Gragoudas E.S., et al. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Opthalmology. 103:1996;1820-1828.
43. Drake D.J., Little C. Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization. Proc Natl Acad Sci USA. 92:1995;7657-7661.
44. Feucht M., Christ B., Witting J. VEGF induces cardiovascular malformation and embryonic lethality. Am J Pathol. 151:1997;1407-1416.
45. Berard M., Sordello S., Ortega N., et al. Vascular endothelial growth factor confers a growth advantage in vitro and in vivo to stromal cells cultured from neonatal hemangiomas. Am J Pathol. 150:1997;1315-1326.
46. Selke F.W., Wang S.Y., Stamler A., Lopez J.J., Li J., Simons M. Enhanced microvascular relaxation to VEGF and bFGF in chronically ischemic porcine myocardium. Am J Physiol. 271:1996;H713-H720.
47. Lopez J.J., Laham R.J., Carrozza J.P., et al. Hemodynamic effects of intracoronary VEGF delivery evidence of tachyphylaxis and NO dependence of response . Am J Physiol. 273:1997;H1317-H1323.
48. Kloner RA, Dow J, Kedes LH. Intramyocardial injection of DNA encoding vascular endothelial growth factor (VEGF) in a myocardial infarction model. 1999, [submitted].
49. Springer M.L., Chen A.S., Kraft P.G., Bednarski M., Blau H.M. VEGF gene delivery to muscle potential role for vasculogenesis in adults . Mol Cell. 2:1998;549-558.
50. Harade K., Friedman M., Lopez J.J., et al. Vascular endothelial growth factor administration in chronic myocardial ischemia. Am J Physiol. 270:1996;H1791-H1802.